This session will showcase the journeys of biotech spin-outs and offer insight on the strategies and lessons learned from their experiences. How to decide whether to licence a technology to an existing company or set up a spin-off company to develop it? What are the key steps and challenges involved in spinning out a company based on academic research? What are the critical factors that contribute to a successful spin-out journey from academia to a start-up?  What can the research group, university of origin or TTO concretely bring to the equation?

Moderator: Markus Lang, Managing Director, Dr Lang Consulting